STARR with CONTOUR® TRANSTAR™ device for obstructed defecation syndrome: one-year real-world outcomes of the European TRANSTAR registry.

Int J Colorectal Dis · 2014 · PMC3996277 · PMID 24554148

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[ 29 ] reported that the SF36 Health Survey score significantly improved after STARR and TRANSTAR, and that TRANSTAR patients showed a trend towards better satisfaction.

also in 53,322 other papers

highly significantno p-value reported

The risk assessment based on the changes in the validated KESS score showed a highly significant, more than ten times (OR = 10.6) reduction in the chance to experience symptoms of ODS at 12 months postoperatively, and the number of patients needed to treat for reaching this benefit was very low (NNT = 2).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.